Navigation Links
9-PCV vaccine found to be helpful in invasive Pneumonococcal infection

Randomized double blind placebo controlled trial was done by Felicity cutts and colleagues in Gambia on the efficacy of // a Nine Valent Pneumococcal Conjugate Vaccine (9-PCV) against radiologically confirmed pneumonia and invasive pneumococcal disesase in children immunized before 12 months of age.

The vaccine was found to reduce the incidence of vaccine type invasive pneumococcal disease by 77%, all serotype invasive Pneumococcal disease by 50%, all the hospital admissions by 15% and overall child mortality by 16%.

The 9-PCV trial reports the higher reduction in the incidence of radiological pneumonia than California and South African studies. The 9-PCV vaccines are used to help the fourth UN Millennium Development Goal in reducing the childhood mortality in developing countries. The evidence for efficacy of the vaccine in all hospital admissions is high.

Chest radiograph has shown high efficacy of the 9-PCV vaccines against pneumonia. The vaccine can also be used as an epidemiological tool to determine the amount of pneumonia due to Pneumococcus. Vaccine efficacy is detected by comparing the percentage reduction of disease incidence in a vaccinated group compared with an unvaccinated group.

In this study the scientists used WHO pneumonia case management algorithm for identifying clinical pneumonia and also WHO radiology standardized guidelines for reading chest radiographs. , Placebo, vaccine trial, nine valent pneumococcal conjugate vaccine, 9PCV, infection, pneumonia, disease, children, serotype, trial report, chest radiograph, WHO.
'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... 2017 , ... Studies show evidence that carotenoids and antioxidants derived either from ... these patients. , But how often do ophthalmologists and optometrists in Sweden recommend the ... of or with early symptoms of AMD? A study published recently in ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will ... 20. , The two-day conference is focused on advancing scientific knowledge about the ... lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance ... With the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more ... 2012, the Biggert-Waters Act was enacted to reflect the actual risk in flood ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... planning services to communities in the greater Chicago metropolitan area, is embarking on ... to underprivileged youth in Chicago. , Founded in 1897, Hephzibah Children’s Association is ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: